HumanMethylation450K Array-Identified Biomarkers Predict Tumour Recurrence/Progression at Initial Diagnosis of High-risk Non-muscle Invasive Bladder Cancer.
Mark O KitchenRichard T BryanRichard D EmesChristopher J LuscombeK K ChengMaurice P ZeegersNicholas D JamesLyndon M GommersallAnthony A FryerPublished in: Biomarkers in cancer (2018)
This is the first genome-wide DNA methylation analysis of a unique HR-NMIBC tumour cohort encompassing known 1-year clinical outcomes. Our analyses identified potential novel epigenetic markers that could help guide individual patient management in this clinically unpredictable disease.